Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone in COVID-19
NCT04273321Completed
- Sponsor
- Beijing Chaoyang Hospital
- Start
- Feb 2020
- Primary completion
- Apr 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of methylprednisolone in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Beijing Chaoyang Hospital. Primary endpoint: Incidence of treatment failure in 14 days. Started Feb 2020; status: completed.
02
Drugs
methylprednisolone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04273321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04273321.